(CLDX) Celldex Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Celldex Therapeutics | (CLDX) share price targets
Complete technical analysis of Celldex Therapeutics (CLDX) by charts plus indicators, forecast predictions and share price targets for Celldex Therapeutics (CLDX)
Celldex Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Celldex Therapeutics is 823430
Date | Daily Closing Price | Open | High | Low | Volume |
03 Thu Apr 2025 | 17.15 | 16.67 | 17.18 | 16.58 | 0.962 times |
02 Wed Apr 2025 | 17.38 | 16.56 | 17.64 | 16.40 | 0.859 times |
01 Tue Apr 2025 | 16.85 | 18.03 | 18.03 | 16.75 | 1.343 times |
31 Mon Mar 2025 | 18.15 | 19.75 | 19.84 | 17.63 | 1.571 times |
28 Fri Mar 2025 | 19.93 | 19.83 | 20.19 | 19.51 | 0.818 times |
24 Mon Mar 2025 | 20.78 | 19.83 | 20.82 | 19.83 | 1.17 times |
21 Fri Mar 2025 | 19.64 | 19.62 | 19.96 | 19.40 | 1.647 times |
20 Thu Mar 2025 | 19.88 | 20.34 | 20.66 | 19.68 | 0.674 times |
19 Wed Mar 2025 | 19.95 | 19.79 | 20.15 | 19.55 | 0.51 times |
18 Tue Mar 2025 | 19.89 | 20.13 | 20.23 | 19.47 | 0.515 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 16.9, for a target of 18.4 or 19.74
Share price targets for Celldex Therapeutics (CLDX)
Target Type | Value |
Downside Target | 16.40 |
Upside Target | 17.63 |
Upside Target | 18.03 |
Upside Target | 18.61 |
Upside Target | 19.40 |
Upside Target | 20.82 |
Upside Target | 21.85 |
Upside Target | 22.33 |
Upside Target | 23.94 |
Upside Target | 24.38 |
Upside Target | 27.74 |
Upside Target | 29.05 |
Intraday share price targets for Celldex Therapeutics (CLDX)
Target Type | Value |
Downside Intraday Target | 15.75 |
Downside Intraday Target | 14.36 |
Upside Intraday Target | 19.19 |
Upside Intraday Target | 21.24 |
Upside Intraday Target | 17.8 |
Weekly technical analysis of Celldex Therapeutics (CLDX)
Date | Weekly Closing Price | Open | High | Low | Volume |
03 Thu Apr 2025 | 17.15 | 19.75 | 19.84 | 16.40 | 2.382 times |
28 Fri Mar 2025 | 19.93 | 19.83 | 20.82 | 19.51 | 0.469 times |
21 Fri Mar 2025 | 19.64 | 20.42 | 21.00 | 19.40 | 0.775 times |
14 Fri Mar 2025 | 20.42 | 20.40 | 21.85 | 18.95 | 1.203 times |
07 Fri Mar 2025 | 20.67 | 21.27 | 22.33 | 18.61 | 0.981 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Celldex Therapeutics (CLDX)
Date | Monthly Closing Price | Open | High | Low | Volume |
03 Thu Apr 2025 | 17.15 | 18.03 | 18.03 | 16.40 | 0.178 times |
31 Mon Mar 2025 | 18.15 | 21.27 | 22.33 | 17.63 | 1.01 times |
28 Fri Feb 2025 | 20.57 | 23.69 | 24.38 | 19.83 | 0.602 times |
31 Fri Jan 2025 | 24.49 | 25.54 | 29.05 | 22.17 | 1.703 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Celldex Therapeutics (CLDX)
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Celldex Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Celldex Therapeutics in short term and the sell signal is strong.
Celldex Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Celldex Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Celldex Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 18.81 and Celldex Therapeutics (CLDX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Celldex Therapeutics (CLDX) stock. Volume based technical analysis of Celldex Therapeutics (CLDX) stock is negative.
Celldex Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Celldex Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Celldex Therapeutics in short term and the sell signal is strong.
Celldex Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Celldex Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Celldex Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 18.81 and Celldex Therapeutics (CLDX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Celldex Therapeutics (CLDX) stock. Volume based technical analysis of Celldex Therapeutics (CLDX) stock is negative.
Celldex Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.